A Mathematical Representation of the Expert Panel's Guidelines for Nigh Blood Cholesterol Case-finding and Treatment

The National Cholesterol Education Program (NCEP) for high blood cholesterol case-finding and treatment recommended discrete treatments according to the results of sequential mea surements of continuous variables (total and low-density lipoprotein cholesterol [LDL-C]). These measurements are subject to intra- and interindividual variability. The authors describe a computer simulation of the NCEP that acknowledges these complexities. The simulation reduces the NCEP into steps, which are represented in a decision tree. The calculation of probabilities at chance nodes takes into account the conditional nature of sequential mea surements of blood cholesterol. The simulation tracks medical resource use and estimates LDL-C reductions within 20 strata, each defining 5% of population distribution for LDL-C. This approach enables a detailed representation of the case-finding process—the sequence of blood cholesterol tests and associated cut-off values that identify individuals needing more intensive evaluation and treatment. Key words: mathematical modeling; screening programs; hypercholesterolemia. (Med Decis Making 1990;10:135-146)

[1]  M Halperin,et al.  Correlations of Plasma High‐density Lipoprotein Cholesterol Levels with Other Plasma Lipid and Lipoprotein Concentrations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.

[2]  M. Schervish.  Multivariate normal probabilities with error bound , 1984 .

[3]  J. Neaton,et al.  The multiple risk factor intervention trial (MRFIT). VII. A comparison of risk factor changes between the two study groups. , 1981, Preventive medicine.

[4]  Stephen E. Fienberg,et al.  Discrete Multivariate Analysis: Theory and Practice , 1976 .

[5]  M. Gardner,et al.  Some effects of within-person variability in epidemiological studies , 1973 .

[6]  L C Gatewood,et al.  Preventing heart disease: is treating the high risk sufficient? , 1988, Journal of clinical epidemiology.

[7]  D H Blankenhorn,et al.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. , 1987, JAMA.

[8]  D R Jacobs,et al.  Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. , 1982, American journal of epidemiology.

[9]  R. P. McDonald,et al.  Structural Equations with Latent Variables , 1989 .

[10]  Daniel Steinberg,et al.  Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. , 1988, Archives of internal medicine.

[11]  S B Hulley,et al.  Distribution of triglyceride and total, LDL and HDL cholesterol in several populations: a cooperative lipoprotein phenotyping study. , 1977, Journal of chronic diseases.

[12]  K E James,et al.  Regression toward the mean in uncontrolled clinical studies. , 1973, Biometrics.

[13]  M J Malloy,et al.  Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen. , 1981, The New England journal of medicine.

[14]  J D Knoke,et al.  Estimating baseline values of the variable of intervention in a clinical trial. , 1985, Controlled clinical trials.

[15]  P. Allhoff,et al.  The Lipid Research Clinics Program Prevalence Study. , 1980, Circulation.

[16]  D R Illingworth,et al.  Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia. , 1984, Annals of internal medicine.

[17]  C. E. Davis,et al.  The effect of regression to the mean in epidemiologic and clinical studies. , 1976, American journal of epidemiology.

[18]  The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. , 1984, JAMA.